Figure 2

Concentration of 14-3-3β proteins in the patient serum samples. Each weekly interval contain the collective serum samples taken from the nine patients at that particular time period. ELISA analysis performed on the serum samples showed significant decrease in 14-3-3β protein levels 2 weeks after admission (Wilcoxon signed-rank test, p = 0.012). 1: admission; 3: Two weeks after presentation; 6: Five weeks after presentation; 9: Eight weeks after presentation). One patient had no follow up data.